| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
McArdle Laboratory for Cancer Research, and Department of Chemistry, University of Wisconsin, Madison, Wisconsin 53706
1'-Hydroxyestragole is a proximate carcinogenic metabolite of the naturally occurring hepatocarcinogen estragole (1-allyl-4-methoxybenzene). Two major (I and II) and 2 minor (III and IV) nucleoside adducts were found by high-performance liquid chromatography (HPLC) of enzymatic hydrolysates of hepatic DNA isolated from adult female CD-1 or preweanling C57BL/6 x C3H/He F1 mice that had been given i.p. injections of 1'-[2',3'-3H]hydroxyestragole. Reaction of 1'-acetoxyestragole, a model electrophilic and mutagenic ester, with [14C]deoxyguanosine ([14C]dGuo) yielded products that coeluted on HPLC with Adducts I, II, and III, while Adduct IV coeluted with a product of the reaction of 1'-acetoxyestragole with [14C]deoxyadenosine. The in vivo adducts did not comigrate with any major reaction products of either 1'-hydroxyestragole-2',3'-oxide or 1'-oxoestragole with [14C]dGuo or [14C]deoxyadenosine. The pH partition coefficient patterns of the in vivo- and in vitro-derived dGuo Adducts I, II, and III together with the 3H:14C ratios of the three adducts from the reaction of 1'-acetoxyestragole with [8-14C,8-3H]dGuo indicated that each of these adducts contains a N2-substituted dGuo residue. Synthetic samples of Adducts II and IV were characterized from their nuclear magnetic resonance spectra and assigned the structures N2-(trans-isoestragol-3'-yl)deoxyguanosine and N2-(trans-isoestragol-3'-yl)deoxyadenosine, respectively. Hydrolysis at 100° with 0.1 N HCl for 30 min of the in vivo Adducts I and II yielded in each case radioactivity which coeluted on HPLC with 3'-hydroxyisoestragole. If Adduct I was first reduced with H2:platinum and then hydrolyzed, radioactivity eluted with 1'-hydroxy-2',3'-dihydroestragole. Adduct I is therefore assigned the structure N2-(estragol-1'-yl)deoxyguanosine. Adduct III was converted in part to Adduct II on chromatography on HPLC and is thus tentatively regarded as N2-(cis-isoestragol-3'-yl)deoxyguanosine. All four adducts in the mouse liver can be accounted for by the reaction of a metabolically derived ester of 1'-hydroxyestragole with purine bases in DNA by SN1, SN2, or SN2' mechanisms.
1 This work was supported by Grants CA-07175 and CA-22484 from the National Cancer Institute, USPHS.
2 Present address: Department of Biological Sciences, Stanford University, Stanford, Calif. 94305.
3 To whom requests for reprints should be addressed.
Received 8/ 9/80. Accepted 10/ 8/80.
This article has been cited by other articles:
![]() |
S.G. Kim, A. Liem, B.C. Stewart, and J.A. Miller New studies on trans-anethole oxide and trans-asarone oxide Carcinogenesis, July 1, 1999; 20(7): 1303 - 1307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |